Last year, the U.S. Food and Drug Administration announced temporary policies aimed at providing manufacturers and businesses with limited flexibility on food labeling requirements and formulation adjustments of products for human consumption during the pandemic. These policies were implemented to provide regulatory flexibility and to minimize the impact of supply chain disruptions on product availability associated with the pandemic. But will these changes also create safety and health issues for consumers? Are these policies likely to continue in this new year?
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
- Educational webcasts, resources from industry leaders, and informative newsletters.
- Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.